According to OPKO Health
's latest financial reports the company has a price-to-book ratio of 0.7844.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 0.8403 | 35.86% |
2022-12-31 | 0.6185 | -68.2% |
2021-12-31 | 1.94 | 22.84% |
2020-12-31 | 1.58 | 159.64% |
2019-12-31 | 0.6098 | -38.11% |
2018-12-31 | 0.9852 | -33.73% |
2017-12-31 | 1.49 | -40.02% |
2016-12-31 | 2.48 | -10.41% |
2015-12-31 | 2.77 | -46.44% |
2014-12-31 | 5.17 | 29.52% |
2013-12-31 | 3.99 | -44.83% |
2012-12-31 | 7.23 | -5.82% |
2011-12-31 | 7.68 | -81.12% |
2010-12-31 | 40.7 | 176.69% |
2009-12-31 | 14.7 | -98.36% |
2008-12-31 | 897 | 2861.26% |
2007-12-31 | 30.3 | -95.6% |
2006-12-31 | 688 | 86593.57% |
2005-12-31 | 0.7933 | 41.35% |
2004-12-31 | 0.5612 | -59.04% |
2003-12-31 | 1.37 | 288.78% |
2002-12-31 | 0.3524 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 4.99 | 536.56% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 4.53 | 477.89% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | 3.95 | 402.97% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 4.93 | 528.54% | ๐บ๐ธ USA |
LabCorp LH | 2.04 | 160.65% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -86.5 | -11,133.06% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 2.54 | 223.50% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | 10.5 | 1,240.22% | ๐บ๐ธ USA |